Myocardial impulse propagation is impaired in right ventricular tissue of Zucker Diabetic Fatty (ZDF) rats

被引:25
|
作者
Olsen, Kristine Boisen [1 ,2 ]
Axelsen, Lene Nygaard [1 ,2 ]
Braunstein, Thomas Hartig [1 ,2 ]
Sorensen, Charlotte Mehlin [2 ]
Andersen, Claus B. [3 ]
Ploug, Thorkil [2 ]
Holstein-Rathlou, Niels-Henrik [1 ,2 ]
Nielsen, Morten Schak [1 ,2 ]
机构
[1] Univ Copenhagen, Danish Natl Res Fdn, Ctr Cardiac Arrhythmia, DK-2200 Copenhagen, Denmark
[2] Univ Copenhagen, Fac Hlth Sci, Dept Biomed Sci, DK-2200 Copenhagen, Denmark
[3] Univ Copenhagen, Rigshosp, Dept Pathol, DK-2200 Copenhagen, Denmark
基金
新加坡国家研究基金会;
关键词
Diabetic cardiomyopathy; Arrhythmia; Lipotoxicity; Conduction velocity; Gap junctions; Type; 2; diabetes; Zucker Diabetic Fatty (ZDF) rats; ANTIARRHYTHMIC PEPTIDE AAP10; GAP JUNCTIONAL CONDUCTANCE; EPICARDIAL BORDER ZONE; REENTRANT CIRCUITS; CARDIAC IMPULSE; GENE-EXPRESSION; CONNEXIN43; HEART; MECHANISMS; ATRIAL;
D O I
10.1186/1475-2840-12-19
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Diabetes increases the risk of cardiovascular complications including arrhythmias, but the underlying mechanisms remain to be established. Decreased conduction velocity (CV), which is an independent risk factor for re-entry arrhythmias, is present in models with streptozotocin (STZ) induced type 1 diabetes. Whether CV is also disturbed in models of type 2 diabetes is currently unknown. Methods: We used Zucker Diabetic Fatty (ZDF) rats, as a model of type 2 diabetes, and their lean controls Zucker Diabetic Lean (ZDL) rats to investigate CV and its response to the anti-arrhythmic peptide analogue AAP10. Gap junction remodeling was examined by immunofluorescence and western blotting. Cardiac histomorphometry was examined by Masson's Trichrome staining and intracellular lipid accumulation was analyzed by Bodipy staining. Results: CV was significantly slower in ZDF rats (56 +/- 1.9 cm/s) compared to non-diabetic controls (ZDL, 66 +/- 1.6 cm/s), but AAP10 did not affect CV in either group. The total amount of Connexin43 (Cx43) was identical between ZDF and ZDL rats, but the amount of lateralized Cx43 was significantly increased in ZDF rats (42 +/- 12 %) compared to ZDL rats (30 +/- 8%), p<0.04. Judged by electrophoretic mobility, Cx43 phosphorylation was unchanged between ZDF and ZDL rats. Also, no differences in cardiomyocyte size or histomorphometry including fibrosis were observed between groups, but the volume of intracellular lipid droplets was 4.2 times higher in ZDF compared to ZDL rats (p<0.01). Conclusion: CV is reduced in type 2 diabetic ZDF rats. The CV disturbance may be partly explained by increased lateralization of Cx43, but other factors are likely also involved. Our data indicates that lipotoxicity potentially may play a role in development of conduction disturbances and arrhythmias in type 2 diabetes.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Vascular and neural dysfunction in Zucker diabetic fatty (ZDF) rats: A difficult condition to reverse
    Yorek, Mark A.
    Davidson, Eric P.
    Coppey, Lawrence J.
    Kleinschmidt, Travis L.
    Oltman, Christine L.
    DIABETES, 2007, 56 : A610 - A610
  • [22] Pharmacokinetics and Efficacy of a Biweekly Dosage Formulation of Exenatide in Zucker Diabetic Fatty (ZDF) Rats
    Hyun-Hee Kwak
    Won-Sik Shim
    Seongmee Hwang
    Mi-Kyung Son
    Yoon-Ji Kim
    Tae-Hyoung Kim
    Zee-Hye Yoon
    Hyun-Jun Youn
    Ghun-Il Lee
    Soo-Hyoung Kang
    Chang-Koo Shim
    Pharmaceutical Research, 2009, 26 : 2504 - 2512
  • [23] Expression of cyclooxygenase (COX) Isoforms in renal cortex of Zucker diabetic fatty rats (ZDF).
    Komers, R
    Cahova, M
    Zdychova, J
    Lindsley, JL
    Kazdova, L
    Anderson, S
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 393A - 393A
  • [24] Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle
    van den Brom, Charissa E.
    Bosmans, Joanna W. A. M.
    Vlasblom, Ronald
    Handoko, Louis M.
    Huisman, Marc C.
    Lubberink, Mark
    Molthoff, Carla F. M.
    Lammertsma, Adriaan A.
    Ouwens, Margriet D.
    Diamant, Michaela
    Boer, Christa
    CARDIOVASCULAR DIABETOLOGY, 2010, 9
  • [25] Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle
    Charissa E van den Brom
    Joanna WAM Bosmans
    Ronald Vlasblom
    Louis M Handoko
    Marc C Huisman
    Mark Lubberink
    Carla FM Molthoff
    Adriaan A Lammertsma
    Margriet D Ouwens
    Michaela Diamant
    Christa Boer
    Cardiovascular Diabetology, 9
  • [26] Detailed Evaluation of Possible Ganglion Cell Loss in the Retina of Zucker Diabetic Fatty (ZDF) Rats
    Rozina I. Hajdú
    Lenke K. Laurik
    Klaudia Szabó
    Bulcsú Dékány
    Zsuzsanna Almási
    Anna Énzsöly
    Arnold Szabó
    Tamás Radovits
    Csaba Mátyás
    Attila Oláh
    Ágoston Szél
    Gábor M. Somfai
    Csaba Dávid
    Ákos Lukáts
    Scientific Reports, 9
  • [27] Detailed Evaluation of Possible Ganglion Cell Loss in the Retina of Zucker Diabetic Fatty (ZDF) Rats
    Hajdu, Rozina, I
    Laurik, Lenke K.
    Szabo, Klaudia
    Dekany, Bulcsu
    Almasi, Zsuzsanna
    Enzsoly, Anna
    Szabo, Arnold
    Radovits, Tunas
    Matyas, Csaba
    Olah, Attila
    Szel, Agoston
    Somfai, Gabor M.
    David, Csaba
    Lukats, Akos
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [28] A clinical and laboratory assessment of Zucker diabetic fatty (ZDF) rats on low or high fat diet
    Pugsley, Michael K.
    Katavolos, Paula
    Walker, Dana B.
    Brooks, Marjory B.
    Koerner, John K.
    Parish, Stanley T.
    Schultze, Albert E.
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2018, 93 : 128 - 128
  • [29] Enhanced synthesis of hydrogen sulfide in liver and kidney from Zucker diabetic Fatty rats (ZDF) compared to Zucker Lean (ZL) rats
    Rashid, Samia
    Alexander, Stephen
    Roberts, Richard
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2013, 31 : S54 - S54
  • [30] Pioglitazone is more potent in prevention than treatment of hyperglycaemia in Zucker diabetic fatty (ZDF) rats
    Szocs, Z.
    Brunmair, B.
    Stadlbauer, K.
    Nowotny, P.
    Bauer, L.
    Luger, A.
    Furnsinn, C.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2007, 115 : S66 - S66